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Kluyvera citrophila penicillin G acylase (KcPGA) has recently attracted
increased attention relative to the well studied and commonly used Escherichia
coli PGA (EcPGA) because KcPGA is more resilient to harsh conditions and
is easier to immobilize for the industrial hydrolysis of natural penicillins to
generate the 6-aminopenicillin (6-APA) nucleus, which is the starting material
for semi-synthetic antibiotic production. Like other penicillin acylases, KcPGA
is synthesized as a single-chain inactive pro-PGA, which upon autocatalytic
processing becomes an active heterodimer of  and  chains. Here, the cloning
of the pac gene encoding KcPGA and the preparation of a slow-processing
mutant precursor are reported. The purification, crystallization and preliminary
X-ray analysis of crystals of this precursor protein are described. The protein
crystallized in two different space groups, P1, with unit-cell parameters a = 54.0,
b = 124.6, c = 135.1 A˚,  = 104.1,  = 101.4,  = 96.5, and C2, with unit-cell
parameters a = 265.1, b = 54.0, c = 249.2 A˚,  = 104.4, using the sitting-drop
vapour-diffusion method. Diffraction data were collected at 100 K and the
phases were determined using the molecular-replacement method. The initial
maps revealed electron density for the spacer peptide.
1. Introduction
Almost 85% of global 6-aminopenicillanic acid (6-APA) production
for the manufacture of semi-synthetic penicillins utilizes penicillin
G acylase (PGA), an enzyme that hydrolyses (Fig. 1) penicillin G
(benzyl penicillin). The majority of the enzyme is sourced from
Escherichia coli. There is interest in PGA enzymes from other
species, such as Kluyvera citrophila (KcPGA), which tolerate harsher
conditions such as higher temperatures, acid/alkaline pH and changes
in solvent composition. These enzymes are easier to immobilize for
applications in the pharmaceutical industry (Alvaro et al., 1992;
Fernandez-Lafuente et al., 1991, 1996; Liu et al., 2006). Improved
industrial standards for the application ofKcPGA can be achieved by
understanding the structure–activity relationship and protein stability
and applying the insights obtained to protein engineering.
The maturation of inactive precursors through post-translational
processing to obtain functional protein forms has long been known in
viral proteins (Douglass et al., 1984; Dougherty & Carrington, 1988),
eukaryotic proteins such as prothrombin and meizothrombin
(Petrovan et al., 1998) and caspases (Stennicke & Salvesen, 1998).
Although initially reported only in eukaryotes (Bussey, 1988), this
was subsequently detected in prokaryotic systems such as Brady-
rhzobium japonicum cytochrome bc1 (Trumpower, 1990), Bacillus
subtilis spore-coat proteins (Aronson et al., 1989), Bacillus polymyxa
amylase (Uozumi et al., 1989), penicillin G acylases (PGAs; Tho¨ny-
Meyer et al., 1992) and -glutamyltranspeptidase (Okada et al., 2007).
The maturation pathway of PGA has been extensively studied for
the E. coli ATCC 11105 enzyme (Bo¨ck et al., 1983). The post-trans-
lational processing of PGA essentially consists of two steps: trans-
location of the precursor to the periplasmic membrane utilizing the
twin arginine translocation (tat) machinery (Ignatova et al., 2002)
followed by autocatalytic intramolecular peptide-bond cleavage. This
autocatalytic processing removes a 26-residue signal peptide and
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a 54-residue linker peptide and results in the formation of active
enzyme in the periplasm, which is a heterodimer of  and  chains of
209 and 557 amino-acid residues, respectively (Choi et al., 1992; Bo¨ck
et al., 1983; Oh et al., 1987). Basically identified as a member of the
Ntn hydrolase superfamily (Brannigan et al., 1995), KcPGA, like
EcPGA, is translated as an inactive precursor (pre-pro-PGA). The
overall sequence identity between EcPGA and KcPGA is 87%
( chain, 84.2%;  chain, 87.6%; spacer peptide, 90.7%). Cleavage of
the Thr289–Ser290 bond leads to the unveiling of the primary amine
group of Ser1 (Ser290 of the precursor), creating the active centre in
mature PGA. The rate-limiting step in the production of active
enzyme is the intramolecular autoproteolytic processing of the
precursor molecule and the final removal of the linker peptide
(Kasche et al., 1999; Hewitt et al., 2000; Done et al., 1998).
Lee et al. (2000) showed that in vitro processing of the precursor
PGA from E. coli was analogous to that observed in in vivo studies
and depended on the pH in the same manner, with an optimum
processing pH in the physiological range 6.4–7.0. A sequence align-
ment of precursor proteins from four Gram-negative and two Gram-
positive bacteria identified a conserved lysine residue (Lys299). Site-
directed mutation of this Lys, which is sequentially close to the
-chain N-terminal serine residue (Ser290), and study using GST-
precursor PGA fusion protein further confirmed that the Lys residue
is the most probable candidate responsible for the pH-dependent
activation. Therefore, activation may involve Lys299 and Ser290
as critical residues for autocatalytic processing of the PGA precursor
(Lee et al., 2000). These residues are also conserved in KcPGA. The
same mechanism, pH and temperature dependence of precursor
autocatalytic processing to yield a processed form is known in other
enzymes (Bron et al., 1998; Little, 1993; Guan et al., 1998). Under-
standing the three-dimensional structure of the precursor and
processing intermediates may unravel the mechanism of action and
the post-translational processing of the industrially useful KcPGA
enzyme.
2. Experimental methods
2.1. Site-directed mutagenesis and transformation
A 2562 bp PCR fragment covering the region 12 nucleotides
upstream from the start codon of the K. citrophila pac gene and 12
nucleotides downstream was amplified using K. citrophila DMSZ
2660 (ATCC 21285) chromosomal DNA as a template, using primers
designed according to the published coding sequence (Barbero et al.,
1986; accession No. M15418). Cleavage sites for the restriction
endonucleases NdeI and XhoI, shown in bold, were included in the
sense (50-CAAGAGGATCATATGAAAAATAGAAATCGTATG-
ATCGTG-30) and antisense (50-GCCGAACTCGAGGCGCTGTA-
CCTGCAGCACTT-30) primer sequences, respectively. The PCR
products were digested using the corresponding restriction enzymes,
purified by gel electrophoresis and inserted into the plasmid
pET26b(+) (EMD Biosciences/Novagen, USA). The ligation
products were used to transform NovaBlue competent cells resistant
to kanamycin. Recombinant plasmids were isolated and their
sequencing confirmed the success of the cloning experiment. This
plasmid pET26-KcPGA was then used as a template for the
preparation of the mutant Ser290Gly (Ser1Gly) using the Quik-
Change site-directed mutagenesis kit (Stratagene, USA). Forward
sense (50-CTACCCGACCACTGGCAATATGTGGGTG-30) and
reverse antisense (50-CACCCACATATTGCCAGTGGTCGGGT-
AG-30) primers were used for mutagenesis, with the site of mutation
shown in bold. The mutagenesis products were used to transform
E. coli NovaBlue cells and the presence of the desired mutations was
confirmed by DNA sequencing.
2.2. Expression and purification
For expression and purification, the expression plasmid pET26-
KcPGA (S290G) was introduced into E. coli BL21 (DE3) pLysS cells.
The transformed E. coli cells were cultured in 2YT (yeast extract
and tryptone) medium supplemented with 35 mg ml1 kanamycin.
The bacterial cells were grown at 310 K with shaking at 250 rev min1
until the OD600 reached 0.8. Isopropyl -d-1-thiogalactopyranoside
(IPTG; Anatrace, USA) was added to the culture to a final concen-
tration of 0.3 mM for induction. The N-terminally His-tagged
Ser1Gly mutant precursor protein was expressed by extending
the culture time by an additional 3 h at 310 K with shaking at
250 rev min1.
The cells were harvested by centrifugation (Beckman/Coulter
Avanti J-26XP) at 5000 rev min1 and 277 K for 30 min. The cell
pellet was resuspended in cold lysis buffer consisting of 50 mM Na
HEPES pH 7.5, 50 mM NaCl, 10 mM -mercaptoethanol, 30 mM
imidazole and the cells were lysed by passage through a micro-
fluidizer (Microfluidics, USA) three times. Cell debris was removed
by centrifugation at 18 000g (Beckman/Coulter Avanti J-26XP) for
20 min at 277 K. A typical nickel-affinity chromatography method
was applied for preliminary purification of the mutant precursor
protein. The supernatant was loaded onto 5 ml Ni–NTA affinity resin
(Qiagen, Germany) pre-equilibrated in lysis buffer. After extensively
crystallization communications
926 Varshney et al.  Penicillin G acylase Acta Cryst. (2013). F69, 925–929
Figure 1
Hydrolysis of penicillin G (benzyl penicillin) by penicillin G acylase (PGA).
washing the resin with lysis buffer, the bound protein was eluted with
elution buffer consisting of 50 mM Na HEPES pH 7.5, 50 mM NaCl,
300 mM imidazole. Fractions containing mutant protein were iden-
tified by 12% SDS–PAGE, pooled and concentrated by centrifuga-
tion (AmiconUltra, Millipore, USA). The protein was further purified
by size-exclusion chromatography on a Superdex 200 16/60 column
(GE Healthcare, USA) with 50 mM Na HEPES pH 7.5, 50 mM NaCl,
1 mM DTT as the mobile phase. The purified mutant precursor
protein was concentrated to 45 mg ml1 in the same buffer for crys-
tallization trials. The purified protein was found to be highly soluble
and could be concentrated to more than 50 mg ml1 without visible
precipitation. The preparation mainly contained the unprocessed
precursor PGA protein with molecular weight 92 kDa as seen on
the SDS–PAGE gel (Fig. 2).
2.3. Crystallization and data collection
Since the Ser290Gly mutant is a slow-processing precursor, crys-
tallization experiments were set up immediately after purification.
Trials were conducted at 293 K using the vapour-diffusion method
with sitting drops consisting of 300 nl protein solution (45 mg ml1)
mixed with 300 nl reservoir solution and equilibrated against 100 ml
reservoir solution. The screens were set up using a Mosquito crys-
tallization robot (TTP LabTech, UK) as sitting-drop vapour-diffusion
experiments in 96-well MRC plates (Hampton Research). Commer-
cial crystallization kits from Hampton Research, Molecular Dimen-
sions, Emerald BioSystems and Qiagen and self-prepared in-house
screens were employed in the screening experiments. Crystals
appeared in one of the self-prepared matrix screens. Multiple thin
plate-like crystals were observed in 30%(w/v) PEG 4000, 50 mM
sodium cacodylate pH 5.6, 0.5M potassium thiocyanate in 3–4 d.
Variation of the pH using similar protein-sample and precipitant
concentrations in drops consisting of 500 nl protein solution and
500 nl well solution set up by a Gryphon crystallization robot (Art
Robbins Instruments, USA) resulted in crystals that grew in a week
under a wide range of pH conditions using 50 mM sodium cacodylate
buffer. The crystals obtained at pH 4.6 and 6.5 diffracted and had a
similar morphology (Fig. 3). These crystals were transferred into
a cryoprotectant solution composed of the reservoir solution
containing 30% glycerol and were flash-cooled in a nitrogen stream at
100 K. Diffraction data were collected at 100 K on beamline BL12-2
at the SLAC National Accelerator Laboratory at the Stanford
Synchrotron Radiation Lightsource (SSRL). Diffraction images were
collected on a DECTRIS PILATUS 6M detector.
3. Results and discussion
The slow-processing mutant precursor of KcPGA (92 kDa) was
purified using previously described protocols. The purity was checked
using SDS–PAGE (Fig. 2), which showed a major band corresponding
to pure precursor protein. Optimization of the crystallization condi-
tions resulted in crystals that grew at two different pH values: 4.6 and
6.5 (Fig. 3). Diffraction data collected from these crystals were inte-
grated using XDS (Kabsch, 2010) and scaled with SCALA in the
CCP4 suite (Winn et al., 2011). Based on the diffraction pattern, the
two crystals obtained at pH 4.6 and 6.5 were indexed in different
space groups. The crystals grown at pH 4.6 belonged to the triclinic
space group P1, with unit-cell parameters a = 54.0, b = 124.6,
c = 135.1 A˚,  = 104.0,  = 101.4,  = 96.5, and diffracted to 2.5 A˚
resolution, whereas crystals obtained at pH 6.5 belonged to the
monoclinic space group C2, with unit-cell parameters a = 265.1,
b = 54.0, c = 249.2 A˚,  = 104.4, and diffracted to 3.5 A˚ resolution
crystallization communications
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Figure 2
Coomassie-stained SDS–PAGE of the slow-processing KcPGA Ser1Gly mutant
following electrophoresis. Left lane, Bio-Rad low-range marker (labelled in kDa);
middle lane, precursor protein after fractionation on a nickel chelation column;
right lane, precursor protein after further purification by size-exclusion chromato-
graphy.
Figure 3
Crystals of the slow-processing Ser1Gly mutant. They appeared within a week
after setting up the drop. (a) Crystals of KcPGA obtained at the low pH of 4.6
(space group P1) as observed using a microscope. The maximum size of the largest
crystal is 200 mm. (b) Crystals of KcPGA obtained at the higher pH of 6.5 (space
group C2) as observed using a Rigaku crystal imager. The maximum size of the
largest crystal is only 80 mm.
(Fig. 4). As the molecular weight of the PGA precursor is 92 kDa, the
Matthews coefficients calculated for four molecules in the asym-
metric unit for the P1 and C2 crystals were 2.48 and 2.51 A˚3 Da1,
respectively, corresponding to solvent contents of 50 and 51%
(Matthews, 1968). The data-collection and processing statistics for
both crystals are summarized in Table 1.
Reflections from the two crystal forms were phased using the
molecular-replacement (MR) method. The structure of the EcPGA
precursor (PDB entry 1e3a; Hewitt et al., 2000), which is the closest
structure to KcPGA, was used as the search model for both data sets.
The AutoMR program from PHENIX (Adams et al., 2002; McCoy
et al., 2007) was used for MR calculations. Executing the PHENIX
AutoMR wizard (Adams et al., 2002) in default mode with 1e3a as a
template resulted in a single solution with an LLG gain of 9234.9, a
rotation-function Z (RFZ) score of 10.1 and a translation-function Z
(TFZ) score of 50.8 for the P1 data set. Similarly, an MR solution was
obtained with the same program suite for the C2 data set. The LLG
gain, RFZ and TFZ scores in this case were 2278.0, 17.1 and 15.9,
respectively. A TFZ score above 8 usually indicates a correct struc-
ture solution (McCoy et al., 2007). A non-origin Patterson peak one-
quarter the height of the origin peak that was found in the case of
the C2 data set may indicate the presence of pseudo-translational
noncrystallographic symmetry (NCS). A pseudo-translational NCS
vector was found at 0.2451, 0.2576 and 0.4973. The initial phases
obtained fromMRwere sufficient for automatic tracing of the protein
structure and preliminary model building. Automatic rebuilding was
performed using the AutoBuild wizard (Terwilliger et al., 2008) from
PHENIX, unchecking the option of adding water molecules. Auto-
Build combines density modification and chain tracing using
RESOLVE (Terwilliger, 2000) and refinement using phenix.refine
(Afonine et al., 2005) to generate a high-quality model. Automated
model building and refinement using AutoBuild built four molecules,
each comprising 3272 of the total 3312 residues of the complete chain
(including the hexahistidine tag), in the asymmetric unit with Rcryst
and Rfree values of 22.9 and 27.5%, respectively, for the P1 data set;
the same 3272 residues were built for the C2 data set with Rcryst and
Rfree values of 35.0 and 42.0%, respectively, yielding sufficiently
informative electron-density maps to evaluate the model. The default
values in phenix.refine (5% of the data) were used to calculate Rfree.
Initial electron-density maps calculated using data from each of the
two crystal forms revealed density for amino acids 236–289 corre-
sponding to the spacer peptide of the KcPGA precursor (Fig. 5). This
is further confirmed by OMIT maps. The presence of electron density
for the spacer, along with molecular-weight determination under
denaturing conditions, confirms that the precursor form of the
molecule has crystallized, although the mutant is known to undergo
slow autocatalytic processing. Since the C2 data have poor resolution
and the P1 data have poor completeness owing to rapid radiation
crystallization communications
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Figure 4
X-ray diffraction patterns obtained from crystals of the KcPGA mutant precursor
crystals (a) in space group P1 and (b) in space group C2. The numbering on the
rings indicates the resolution of the data. The spots at the edges could be owing to
buffer/salt.
Table 1
Data-collection and processing statistics for the two crystal forms of the slow-
processing mutant of KcPGA.
Values in parentheses are for the outermost resolution shell.
Space group P1 C2
Temperature (K) 100 100
X-ray source BL12-2, SSRL BL12-2, SSRL
Wavelength (A˚) 0.9560 0.9560
Unit-cell parameters (A˚, ) a = 54.0, b = 124.6,
c = 135.1,  = 104.1,
 = 101.4,  = 96.5
a = 265.1, b = 54.0,
c = 249.2,  = 104.4
Molecules per asymmetric unit 4 4
Matthews coefficient (A˚3 Da1) 2.48 2.51
Solvent content (%) 50 51
Total No. of observations 148560 125434
No. of unique observations 87317 42189
Multiplicity 1.7 (1.6) 3.0 (3.1)
Resolution range (A˚) 38.6–2.5 (2.6–2.5) 38.8–3.5 (3.7–3.5)
Average I/(I) 6.1 (1.2) 4.0 (2.8)
Rmerge† (%) 9.5 (55.1) 26.1 (40.5)
Rmeas‡ (%) 13.4 (78.0) 31.7 (48.9)
Rp.i.m.§ (%) 9.5 (55.1) 17.8 (27.1)
CC1/2 98.9 (59.9) 94.1 (78.5)
Completeness (%) 76.5 (80.6) 96.0 (96.5)
† Rmerge =
P
hkl
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ. ‡ Rmeas =
P
hklfNðhklÞ=
½NðhklÞ  1g1=2Pi jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ. § Rp.i.m. =
P
hklf1=
½NðhklÞ  1g1=2Pi jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ.
damage, neither could be used for complete refinement. Efforts are
ongoing to achieve higher resolution and complete data.
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Figure 5
(a) The model of KcPGA shown was obtained after carrying out MR calculations
and the first cycle of refinement. The spacer peptide is highlighted and the rest of
the molecule is shown as a C trace. The N- and C-termini are labelled. (b) The
spacer peptide is shown overlapping with 2Fo  Fc (grey colour, 1 level) and
Fo  Fc (blue, 3) maps. This figure was prepared using PyMOL v.1.5.0.2
(Schro¨dinger LLC.).
